Scholars Central

Conference abstractPublished 14 Apr 2014

Reactivation of fetal splicing programs in diabetic hearts

Authors: Muge N. Kuyumcu-Martinez, Sunil K. Verma, Vaibhav Deshmukh, Patrick Liu, Curtis A. Nutter, Rosario Espejo, Ming-Lung Hung, Guey-Shin Wang, Gene W. Yeo

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Diabetic cardiomyopathy can lead to heart failure and death among diabetics independent of effects from hypertension and coronary heart disease. Chronic activation of Protein Kinase C (PKC) signaling promotes diabetic cardiomyopathy by mechanisms that are not well understood. PKC has been implicated in alternative splicing (AS) regulation in the heart. Aim: Our goal is to determine whether prolonged PKC activity induces alternative splicing abnormalities in diabetic hearts. Methods: We performed RNA sequencing followed by computational analysis using MISO algorithm to distinguish AS patterns in diabetic versus normal mouse hearts. We used two Type 1 diabetes mouse models (non-obese diabetic and Streptozotocin induced) as well as Type 2 human heart tissues to validate alternative splicing changes by quantitative RT-PCR. Using PKC inhibitors or PKC alpha/beta specific shRNAs, we identified which AS changes in diabetic hearts are controlled by PKC. Splicing changes that are altered in diabetic hearts were targets of a splicing regulator called CELF1. Therefore, we mutated PKC phosphorylation sites on CELF1 to determine the effect of phosphorylation on CELF1 regulated genes that are mis- spliced in diabetes. Results: We found genome wide alternative splicing changes in diabetic hearts and identified a set of 22 AS events that reverse to a fetal splicing pattern in adult diabetic hearts. GO analysis indicates that the genes that undergo a developmental AS switch in diabetic hearts have important functions in embryonic development and RNA metabolism. Importantly, PKC isozymes alpha and beta control alternative splicing of these genes in fetal hearts via phosphorylation of splicing regulator CELF1. A mutant of CELF1 that is non-phosphorylatable by PKC can no longer regulate splicing events altered in diabetic hearts. Conclusion: PKC contributes to diabetic cardiomyopathy by activating embryonic splicing programs in adult hearts.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Muge N. Kuyumcu-Martinez”
  • BylineArticles whose byline prints “Sunil K. Verma”
  • BylineArticles whose byline prints “Vaibhav Deshmukh”
  • BylineArticles whose byline prints “Patrick Liu”
  • BylineArticles whose byline prints “Curtis A. Nutter”
  • BylineArticles whose byline prints “Rosario Espejo”
  • BylineArticles whose byline prints “Ming-Lung Hung”
  • BylineArticles whose byline prints “Guey-Shin Wang”